Replication validity of genetic association studies

被引:1449
作者
Ioannidis, JPA [1 ]
Ntzani, EE
Trikalinos, TA
Contopoulos-Ioannidis, DG
机构
[1] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece
[2] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin Trials & Evidence Based Med Unit, GR-45110 Ioannina, Greece
[3] Ioannina Biomed Res Inst, GR-45110 Ioannina, Greece
[4] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA
[5] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20010 USA
关键词
D O I
10.1038/ng749
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The rapid growth of human genetics creates countless opportunities for studies of disease association. Given the number of potentially identifiable genetic markers and the multitude of clinical outcomes to which these may be linked, the testing and validation of statistical hypotheses in genetic epidemiology is a task of unprecedented scale(1,2). Meta-analysis provides a quantitative approach for combining the results of various studies on the same topic, and for estimating and explaining their diversity(3,4). Here, we have evaluated by meta-analysis 370 studies addressing 36 genetic associations for various outcomes of disease. We show that significant between-study heterogeneity (diversity) is frequent, and that the results of the first study correlate only modestly with subsequent research on the same association. The first study often suggests a stronger genetic effect than is found by subsequent studies. Both bias and genuine population diversity might explain why early association studies tend to overestimate the disease protection or predisposition conferred by a genetic polymorphism. We conclude that a systematic meta-analytic approach may assist in estimating population-wide effects of genetic risk factors in human disease.
引用
收藏
页码:306 / 309
页数:4
相关论文
共 23 条
  • [1] Large trials vs meta-analysis of smaller trials - How do their results compare?
    Cappelleri, JC
    Ioannidis, JPA
    Schmid, CH
    deFerranti, SD
    Aubert, M
    Chalmers, TC
    Lau, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (16): : 1332 - 1338
  • [2] Cooper H., 1994, HDB RES SYNTHESIS, V1st
  • [3] METAANALYSIS IN CLINICAL-TRIALS
    DERSIMONIAN, R
    LAIRD, N
    [J]. CONTROLLED CLINICAL TRIALS, 1986, 7 (03): : 177 - 188
  • [4] PUBLICATION BIAS IN CLINICAL RESEARCH
    EASTERBROOK, PJ
    BERLIN, JA
    GOPALAN, R
    MATTHEWS, DR
    [J]. LANCET, 1991, 337 (8746) : 867 - 872
  • [5] GERSHON ES, 1994, GENETIC APPROACHES M
  • [6] Greenberg DA, 1999, GENET EPIDEMIOL, V17, pS429
  • [7] Gu C, 1999, GENET EPIDEMIOL, V17, pS599
  • [8] Hedges L. V., 1985, Statistical methods for meta-analysis
  • [9] Hosmer D. W., 1989, APPL LOGISTIC REGRES, DOI DOI 10.1097/00019514-200604000-00003
  • [10] Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials
    Ioannidis, JPA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (04): : 281 - 286